Nuclear Medicine Instrumentation Market - Global Forecast 2026-2032

The nuclear medicine instrumentation market is evolving rapidly, driven by technological innovation and shifts in clinical practice. Senior leaders must track operational, regulatory, and economic trends to future-proof their organizations and identify growth opportunities across diverse healthcare settings.

Market Snapshot: Nuclear Medicine Instrumentation Market Growth Drivers

The nuclear medicine instrumentation market is showing strong momentum, advancing from USD 4.51 billion in 2025 to USD 4.81 billion in 2026, with a CAGR of 7.00% projected to reach USD 7.25 billion by 2032. Escalating demand for precision diagnostics, ongoing advancements in radiotracers, and a surge in adoption of hybrid imaging platforms are reshaping the landscape globally. Influencers include evolving reimbursement frameworks, shifting regulatory requirements, and the sector-wide need for enhanced operational efficiency. Senior decision-makers must be alert to these dynamics to respond proactively and steer their organizations effectively.

Scope & Segmentation: Comprehensive Market Coverage

This market intelligence delivers detailed segmentation to support targeted strategies and maximize competitive positioning:

Technology Platforms: Offerings comprise standalone PET and SPECT systems, integrated hybrid imaging such as PET/CT and SPECT/CT, and advanced digital and software-enabled solutions, supporting modernization and workflow optimization.
Product Types: Encompasses diagnostic equipment like gamma cameras and tomographic scanners, alongside therapeutic products including automated radiopharmaceutical dispensers and radionuclide delivery technologies.
Radiopharmaceuticals: Expanding range of tracers enables imaging for cardiology, neurology, and oncology, empowering providers to tailor diagnostics and therapy planning more precisely.
End Users: Covers dedicated imaging centers, large hospital networks, as well as academic and research institutions, each with differing procurement priorities and operational needs.
Regional Markets: Focuses on the Americas; Europe, Middle East & Africa (EMEA); and Asia Pacific. Each region is shaped by unique infrastructure maturity, reimbursement policies, and investment cycles, requiring region-specific strategies to unlock value.

This robust segmentation framework supports leaders in evaluating growth strategies and operational models adaptable to ever-changing clinical and regulatory settings.

Key Takeaways: Strategic Insights for Decision-Making

Modern nuclear medicine instrumentation delivers access to molecular-level clinical data, enhancing disease detection and refining therapy planning for improved treatment pathways.
Hybrid imaging platforms are gaining traction, as they combine both functional and anatomical insights, streamlining clinical workflows and broadening diagnostic and theranostic applications.
Artificial intelligence and machine learning are increasingly integrated, optimizing image interpretation, supporting efficient workflow management, and enabling predictive maintenance for critical imaging equipment.
Collaboration among equipment manufacturers, software firms, and end users accelerates innovation cycles and facilitates expanded market reach through co-development agreements.
Adoption rates across regions are shaped by health system infrastructure, reimbursement coding, and support networks, requiring tailored market entry and support approaches for success.
Providers are addressing cost considerations by utilizing modular instrument solutions and bundled service contracts, which support stepwise upgrades and maximize asset lifecycle value.

Tariff Impact: Operational and Supply Chain Considerations

Recent US tariffs imposed in 2025 on medical device components have intensified supply chain management challenges. Manufacturers are reevaluating sourcing strategies, accelerating localization of production, and expanding supplier networks to mitigate risk. Healthcare providers, in response to increased import duties and capital constraints, are reassessing budget allocations, prioritizing flexible service contracts, and adopting modular equipment. Distributors are increasing inventory buffers to maintain consistent supply, while regulatory bodies are streamlining approval pathways for domestic alternatives. These shifts collectively promote resilient, regionally oriented supply strategies that balance cost control with sustained technology adoption across the supply chain.

Methodology & Data Sources

This analysis uses a rigorous methodology, synthesizing data from peer-reviewed articles, patent filings, technical reports, and regulatory submissions. Direct interviews with engineers, clinicians, procurement leads, and regulatory experts enrich secondary research. Data triangulation ensures insight reliability, relevance, and actionable precision for senior stakeholders.

Why This Report Matters to Senior Leaders

Enables informed investment by mapping technology evolution, regulatory developments, and market segmentation nuances within nuclear medicine instrumentation.
Supports strategic planning through insight into supply chain shifts, regional standards, and emerging operational priorities across end-user organizations.
Prepares leadership teams with actionable recommendations, helping them anticipate disruption and translate market complexity into sustainable competitive advantage.

Conclusion

This comprehensive overview equips decision-makers with the strategic perspective needed to adapt to ongoing advances in nuclear medicine instrumentation. Well-informed leadership will be positioned to drive sustainable growth and encourage innovation amidst evolving clinical and operational demands.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Nuclear Medicine Instrumentation Market, by Technology

8.1. Hybrid Imaging
8.1.1. PET/CT Systems
8.1.2. SPECT/CT Systems
8.2. Positron Emission Tomography
8.3. Single Photon Emission Computed Tomography

9. Nuclear Medicine Instrumentation Market, by Product Category

9.1. Diagnostic Instruments
9.2. Therapeutic Instruments & Radiopharmaceuticals

10. Nuclear Medicine Instrumentation Market, by Application

10.1. Cardiology
10.2. Neurology
10.3. Oncology

11. Nuclear Medicine Instrumentation Market, by End User

11.1. Diagnostic Imaging Centers
11.2. Hospitals
11.3. Research Institutes

12. Nuclear Medicine Instrumentation Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Nuclear Medicine Instrumentation Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Nuclear Medicine Instrumentation Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Nuclear Medicine Instrumentation Market
16. China Nuclear Medicine Instrumentation Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AMETEK Inc.
17.6. B J Madan & Co
17.7. Berthold Technologies GmbH & Co.KG
17.8. Blue Earth Diagnostics
17.9. Bruker Corporation
17.10. Canon Medical Systems Corporation
17.11. Cardinal Health
17.12. COMECER SpA
17.13. Digirad
17.14. Exosens
17.15. GE Healthcare
17.16. Geebee International
17.17. Hidex Oy
17.18. Jubilant DraxImage, Inc.
17.19. Koninklijke Philips N.V.
17.20. Mirion Technologies, Inc.
17.21. Neusoft Medical Systems Co., Ltd.
17.22. Nucleonix Systems (P) Ltd.
17.23. Nucleuz Healthcare Pvt Ltd
17.24. NUVIATech Healthcare
17.25. OVIS Imaging Solutions
17.26. Radiation Monitoring Devices
17.27. Rotem Industries Ltd.
17.28. Siemens Healthineers AG
17.29. Spectrum Instrumentation

List of Figures

FIGURE 1. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. EUROPE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. EUROPE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 73. EUROPE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 74. EUROPE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 75. EUROPE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. MIDDLE EAST NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 85. AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 86. AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 87. AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. ASEAN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. ASEAN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. ASEAN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 99. ASEAN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 100. ASEAN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. ASEAN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GCC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GCC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. GCC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 105. GCC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 106. GCC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. GCC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. BRICS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. BRICS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. BRICS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 117. BRICS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 118. BRICS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. BRICS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. G7 NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. G7 NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. G7 NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 123. G7 NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 124. G7 NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. G7 NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. NATO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NATO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. NATO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 129. NATO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 130. NATO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. NATO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2032 (USD MILLION)
TABLE 142. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 143. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. CHINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

AMETEK Inc.
B J Madan & Co
Berthold Technologies GmbH & Co.KG
Blue Earth Diagnostics
Bruker Corporation
Canon Medical Systems Corporation
Cardinal Health
COMECER SpA
Digirad
Exosens
GE Healthcare
Geebee International
Hidex Oy
Ion Beam Applications S.A.
Jubilant DraxImage, Inc.
Koninklijke Philips N.V.
Mediso Medical Imaging Systems, Inc.
Mirion Technologies, Inc.
Neusoft Medical Systems Co., Ltd.
Nucleonix Systems (P) Ltd.
Nucleuz Healthcare Pvt Ltd
NUVIATech Healthcare
OVIS Imaging Solutions
PerkinElmer, Inc.
Radiation Monitoring Devices
Rotem Industries Ltd.
Siemens Healthineers AG
Spectrum Dynamics Medical Ltd.
Spectrum Instrumentation

Table Information

Report Attribute	Details
No. of Pages	187
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 4.81 Billion
Forecasted Market Value ( USD ) by 2032	$ 7.25 Billion
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	29

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Nuclear Medicine Instrumentation Market Growth Drivers

Scope & Segmentation: Comprehensive Market Coverage

Key Takeaways: Strategic Insights for Decision-Making

Tariff Impact: Operational and Supply Chain Considerations

Methodology & Data Sources

Why This Report Matters to Senior Leaders

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2025-2030

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2025-2030

Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2025-2033

Nuclear Medicine Equipment Market by Product (Imaging: PET, SPECT, Gamma; GM Counter, Dose Calibrator), Software (Image Management, PACS, Treatment, Analytic, Workflow), Therapy (Onco, Cardio, Neuro, Ortho), End User & Region - Global Forecasts to 2030

Nuclear Medicine Market Report and Forecast 2025-2034